Status:
UNKNOWN
mHealth Intervention to Increase Physical Activity in Prediabetes and Type 2 Diabetes
Lead Sponsor:
Charles University, Czech Republic
Collaborating Sponsors:
University of Hradec Kralove
St George's, University of London
Conditions:
Type 2 Diabetes
PreDiabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sedentary behaviour has a detrimental effect on the mortality, morbidity, and well-being of patients with type 2 diabetes and prediabetes, and general practitioners should advise patients on how to se...
Eligibility Criteria
Inclusion
- Diagnosis of prediabetes or T2DM according to the Czech guidelines for GPs on diabetes mellitus1 and prediabetes2, i.e. fasting plasma glucose 5.6-6.9 mmol/l, or 2-h plasma glucose of 7.8-11.0 mmol/l after ingestion of 75 g of oral glucose load for the diagnosis of prediabetes, and fasting plasma glucose ≥ 7.0 mmol/l, or 2-h plasma glucose ≥ 11.1 mmol/l after ingestion of 75 g of the oral glucose load for the diagnosis of T2DM
- Age 18 years or older.
- Registered at a participating general practice.
- Regular users of a smartphone and willing to use it as part of the study.
- Written informed consent obtained before any assessment related to the study.
Exclusion
- unable to walk
- pregnancy
- taking insulin
- living in a residential or nursing care home
- co-morbid conditions that would affect their adherence to the trial procedures
Key Trial Info
Start Date :
April 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT05351359
Start Date
April 25 2022
End Date
June 1 2024
Last Update
October 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of General Practice
Prague, Czechia